Updated On: 18 November, 2020 08:23 AM IST | New York | Agencies
If FDA allows emergency use of shots, therell be limited supplies by year end

Business owners and local leaders protest against new COVID-19 regulations in San Diego, California, on Monday. Pic/AFP
A second experimental COVID-19 vaccine — this one from Moderna Inc. — yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase.
Moderna said its vaccine appears to be 94.5 per cent effective, according to preliminary data from an ongoing study. A week ago, competitor Pfizer Inc. announced its own vaccine looked 90 per cent effective — news that puts both firms on track to seek nod within weeks for emergency use in the US. The results are "truly striking," said Dr Anthony Fauci, the US government's top infectious-diseases expert.